Video Archive

01:59:24

In Committee from the House of Commons

Health – October 21, 2026

Opioid Epidemic and Toxic Drug Crisis in Canada Witnesses As an individual Dr. Pouya Azar, Physician (by videoconference) Assembly of First Nations Wendell LaBobe, Regional Chief, Prince Edward Island (by videoconference) Direction régionale de santé publique de Montréal Dr. David Kaiser, Deputy Medical Director As an individual Dr. Nickie Mathew, Addiction Psychiatrist (by videoconference) Dr. Julian M. Somers, Clinical Psychologist, Full Professor (by videoconference) Métis Nation-Saskatchewan Beverly Fullerton-Trotchie, Minister of Health, Mental Health and Addictions Brennan Merasty, Minister of Self Determination and Self Government Source: ourcommons.ca

02:05:01

In Committee from the House of Commons

Health – October 7, 2026

Bill C-224, An Act to amend the Food and Drugs Act (natural health products) Witnesses Blaine Calkins, M.P., Ponoka—Didsbury Department of Health Sara O'Connor, Director General, Health Product Compliance Directorate Kim Godard, Director General, Natural and Non-Prescription Health Products Directorate Source: ourcommons.ca

02:07:02

In Committee from the House of Commons

June 2, 2026

Health – May 7, 2026

Canada's Pharmaceutical Sovereignty Witnesses Best Medicines Coalition Kim Steele, Chair (by videoconference) Canadian Health Food Association Sonia Parmar, Vice President, Government Relations and Regulatory Affairs Groupement provincial de l'industrie du médicament Stéphane Lévesque, General Manager AbCellera Biologics Inc. Carl Hansen, Chief Executive Officer (by videoconference) BIOTECanada Wendy Zatylny, President and Chief Executive Officer Ron Boch, Vice President, Biotechnology and Industry Affairs Amended Vimy Pharmaceuticals Inc. David Suchon, Founder and Chief Executive Officer Source: ourcommons.ca

00:14:28

In Committee from the House of Commons

Health – April 28, 2026

Election of Chair Meeting Requested Pursuant to Standing Order 106(4) to Discuss the Committee's Investigation on PrescribeIT Program Source: ourcommons.ca

02:00:25

In Committee from the House of Commons

Health – April 16, 2026

Briefing with the Canadian Center on Substance Use and Addiction Witnesses Canadian Centre on Substance Use and Addiction Dr. Alexander Caudarella, Chief Executive Officer Neil Arao, Board Member (by videoconference) Scott Elliott, Board Member (by videoconference) Susan Russell-Csanyi, Board Member (by videoconference) Dr. Louis Hugo Francescutti, Board Member (by videoconference) Source: ourcommons.ca

02:14:40

In Committee from the House of Commons

Health – March 26, 2026

Canada’s Pharmaceutical Sovereignty Canadian Medical Association Dr. Margot Burnell, President Grifols Canada Mary Hughes, Vice-President, Sales and Commercial Operations Médicament Québec Arianne Trudeau, Executive Director As an individual Dr. Martyn Judson, Addictionist Dr. Mina Tadrous, Associate Professor, University of Toronto Canadian Pharmacists Association Dr. Sadaf Faisal, Interim Vice President, Public and Professional Affairs Source: ourcommons.ca

01:35:35

In Committee from the House of Commons

March 24, 2026

Health – March 12, 2026 (Part 2 of 2)

Supplementary Estimates (C), 2025-26: Vote 5c under Canadian Institutes of Health Research, Vote 10c under Department of Health, Votes 1c and 10c under Public Health Agency of Canada Source: ourcommons.ca

02:20:24

In Committee from the House of Commons

Health – March 12, 2026 (Part 1 of 2)

Supplementary Estimates (C), 2025-26: Vote 5c under Canadian Institutes of Health Research, Vote 10c under Department of Health, Votes 1c and 10c under Public Health Agency of Canada Appearing Marjorie Michel, P.C., M.P., Minister of Health Witnesses Canadian Food Inspection Agency Robert Ianiro, Vice-President, Policy and Programs Canadian Institutes of Health Research Dr. Paul Hébert, President Department of Health Shalene Curtis-Micallef, Deputy Minister Jocelyne Voisin, Senior Assistant Deputy Minister, Health Policy BranchAmended Pamela Aung-Thin, Assistant Deputy Minister, Health Products and Food Branch Matt Jones, Assistant Deputy Minister, Healthy Environments and Consumer Safety Branch Sarah Lawley, Assistant Deputy Minister, Health Policy Branch Lynne René de Cotret, Assistant Deputy Minister, Oral Health Branch Kendal Weber, Assistant Deputy Minister, Controlled Substances and Cannabis Branch Ryan Higgs, Acting Assistant Deputy Minister and Chief Financial Officer Public Health Agency of Canada Nancy Hamzawi, President Kerry Robinson, Vice-President, Infectious Diseases and Vaccination Programs Branch Public Health Agency of Canada Rod Greenough, Vice-President and Chief Financial Officer Stacey Mantha, Director General, Regulatory, Operations and Emergency Management Branch Source: ourcommons.ca

01:02:50

In Committee from the House of Commons

Health – February 26, 2026

Bill C-234, An Act respecting the establishment and award of a Living Donor Recognition Medal Witnesses Ziad Aboultaif, M.P., Edmonton Manning As an individual Christopher McCreery, Author and Historian (by videoconference) Privy Council Office Joël Girouard, Senior Privy Council Officer, Machinery of Government Source: ourcommons.ca

01:23:34

In Committee from the House of Commons

Health – February 24, 2026

This meeting is a continuation of a previous meeting from February 12, 2026. CPAC brings viewers a detailed examination of policy matters through broadcasts of select House of Commons committees.

02:24:24

In Committee from the House of Commons

Health – February 12, 2026

CPAC brings viewers a detailed examination of policy matters through broadcasts of select House of Commons committees.

02:04:07

In Committee from the House of Commons

Health – February 5, 2026

Subject Matter of Clauses 400 to 456 (Division 25) of Bill C-15, An Act to implement certain provisions of the budget tabled in Parliament on November 4, 2025 Appearing Marjorie Michel, P.C., M.P., Minister of Health Witnesses Canadian Food Inspection Agency Robert Ianiro, Vice-President, Policy and Programs Canadian Institutes of Health Research Dr. Paul Hébert, President Department of Health Shalene Curtis-Micallef, Deputy Minister Jocelyne Voisin, Senior Assistant Deputy Minister, Health Policy Branch Pamela Aung-Thin, Assistant Deputy Minister, Health Products and Food Branch Matt Jones, Assistant Deputy Minister, Healthy Environments and Consumer Safety Branch Kendal Weber, Assistant Deputy Minister, Controlled Substances and Cannabis Branch Ryan Higgs, Acting Assistant Deputy Minister and Chief Financial Officer Public Health Agency of Canada Nancy Hamzawi, President Kimby Barton, Director General, Centre for Biosecurity, Regional Operations and Emergency Management Branch Public Health Agency of Canada Dr. Natasha Crowcroft, Acting Chief Public Health Officer Source: ourcommons.ca

02:17:56

In Committee from the House of Commons

Health – January 27, 2026

Antimicrobial Resistance Witnesses As an individual Dr. Isaac Bogoch, Professor of Medicine, University of Toronto Dr. Victor Leung, Infectious Diseases Physician and Medical Microbiologist Dr. Karl Weiss, Chief, Division of Infectious Diseases and Microbiology, Jewish General Hospital Gerry Wright, Professor, McMaster University McGill University Health Centre Dr. Makeda Semret, Associate Professor of Medicine, Infectious Diseases and Medical Microbiology Patients for Patient Safety Canada Kim Neudorf, Patient Partner Source: ourcommons.ca

02:12:05

In Committee from the House of Commons

Health – December 9, 2025

Subject Matter of Supplementary Estimates (B), 2025-26: Vote 1b under Canadian Food Inspection Agency, Vote 5b under Canadian Institutes of Health Research, Votes 1b and 10b under Department of Health and Votes 1b and 10b under Public Health Agency of Canada Witnesses Department of Health Greg Orencsak, Deputy Minister Jocelyne Voisin, Senior Assistant Deputy Minister, Health Policy Branch Lynne René de Cotret, Assistant Deputy Minister, Oral Health Branch Kendal Weber, Assistant Deputy Minister, Controlled Substances and Cannabis Branch Ryan Higgs, Acting Assistant Deputy Minister and Chief Financial Officer Public Health Agency of Canada Nancy Hamzawi, President Dr. Natasha Crowcroft, Acting Chief Public Health Officer and Vice-President, Infectious Diseases and Vaccination Programs Branch Stephen Bent, Vice-President, Regulatory, Operations and Emergency Management Branch Rod Greenough, Vice-President and Chief Financial Officer Canadian Food Inspection Agency Robert Ianiro, Vice-President, Policy and Programs Canadian Institutes of Health Research Jeff Moore, Acting Executive Vice-President Jimmy Fecteau, Chief Financial Officer Antimicrobial Resistance Witnesses Canadian Institutes of Health Research Dr. Charu Kaushic, Scientific Director, Institute of Infection and Immunity (by videoconference) Source: ourcommons.ca

02:11:30

In Committee from the House of Commons

Health – December 2, 2025

Antimicrobial Resistance Witnesses ATMIS Scot Magnish, Director of Communications and Public Affairs Canadian Society of Healthcare-Systems Pharmacy Dr. Rita Dhami, Chief Pharmacy Officer (by videoconference) Infection Prevention and Control Canada Dr. Kevin Stinson, Program Manager, Infection Prevention and Control, Waterloo Regional Health Network (by videoconference) Western University Dr. Sameer Elsayed, Infectious Diseases Physician (by videoconference) Winnipeg Regional Health Authority Dr. Terry Wuerz, Infectious Diseases Physician Source: ourcommons.ca

02:05:26

In Committee from the House of Commons

Health – November 18, 2025

Impact of Immigration Policy on Healthcare and Barriers to Integrating Internationally Trained Professionals Appearing Hon. Lena Metlege Diab, P.C., M.P., Minister of Immigration, Refugees and Citizenship Hon. Marjorie Michel, P.C., M.P., Minister of Health Witnesses Department of Citizenship and Immigration Louise Baird, Senior Assistant Deputy Minister, Strategic Policy Soyoung Park, Assistant Deputy Minister, Economic Programs Department of Health Jocelyne Voisin, Senior Assistant Deputy Minister, Health Policy Branch Greg Orencsak, Deputy Minister Michelle Owen, Executive Director, Health Human Resources Task Force Source: ourcommons.ca

02:08:02

In Committee from the House of Commons

Health – November 6, 2025

Impact of Immigration Policy on Healthcare and Barriers to Integrating Internationally Trained Professionals Witnesses Catholic Community Services of York Region Dr. Ali Amiri, International Medical Doctor Dr. Antanina Hulko, International Medical Doctor Canadian Physiotherapy Association Krissy Bell, Chief Executive Officer World Education Services Shamira Madhany, Managing Director, Canada and Deputy Executive Director (by videoconference) Canadian Association of Emergency Physicians Dr. Elizabeth Shouldice, Chair, Public Affairs Committee Dr. Michael Herman, Vice-Chair, Public Affairs Committee Canadian Medical Association Dr. Margot Burnell, President (by videoconference) Canadian Pharmacists Association Sadaf Faisal, Senior Director, Professional Affairs Source: ourcommons.ca

01:57:25

In Committee from the House of Commons

Health – November 4, 2025

Impact of Immigration Policy on Healthcare and Barriers to Integrating Internationally Trained Professionals Witnesses Canadian Association for Long Term Care Jodi Hall, Chief Executive Officer (by videoconference) Town of Oliver Martin Johansen, Mayor Alberta International Medical Graduates Association Deidre Lake, Executive Director As an individual Dr. Shazeen Suleman, Clinical Associate Professor, Stanford University (by videoconference) Canadian Federation of Nurses Unions Linda Silas, President (by videoconference) Baljinder Singh, Member, Internationally Educated Nurses Advisory Committee (by videoconference) Source: ourcommons.ca

02:02:56

In Committee from the House of Commons

Health – October 30, 2025

Impact of Immigration Policy on Healthcare and Barriers to Integrating Internationally Trained Professionals Witnesses As an individual Dr. Pantea Barati, Doctor (by videoconference) Dr. Sandra Rao, Emergency Physician Canadian Nurses Association Valerie Grdisa, Chief Executive Officer (by videoconference) American Canadian School of Medicine Dr. Andrew Padmos, Executive Vice-President Source: ourcommons.ca

02:36:20

In Committee from the House of Commons

Health – October 28, 2025

The committee continues its study of the impact of immigration policy on healthcare and barriers to integrating internationally trained professionals. Appearing as witnesses are Geoffrey Barnum (Senior Manager, Data at the Canadian Post-M.D. Education Registry), Eva Slawecki (Advisor, Canadian Medical Foundation at Internationally Educated Health Professionals in Canada), Dr. Viren Naik (Chief Executive Officer of the Medical Council of Canada), Rosemary Pawliuk (President of the Society for Canadians Studying Medicine Abroad), Dr. Douglas Munkley (Physician with the Society for Canadians Studying Medicine Abroad), Dr. Arun Anand (Physician) and Dr. Scott Alexander (Medical Advisor).

Filter by Date